miR-143 Inhibits NSCLC Cell Growth and Metastasis by Targeting Limk1

被引:49
|
作者
Xia, Hui [1 ]
Sun, Shengjie [2 ]
Wang, Bo [3 ]
Wang, Tao [3 ]
Liang, Chaoyang [3 ]
Li, Guo [3 ]
Huang, Chongbiao [4 ]
Qi, Daliang [4 ]
Chu, Xiangyang [3 ]
机构
[1] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Thorac Cardio Surg, Beijing 100048, Peoples R China
[2] Gen Hosp Peoples Liberat Army, Dept Med Oncol, Beijing 100853, Peoples R China
[3] Gen Hosp Peoples Liberat Army, Dept Thorac Surg, Beijing 100853, Peoples R China
[4] Tianjin Med Univ, Canc Inst & Hosp, Dept Senior Ward, Key Lab Canc Prevent & Therapy Tianjin, Tianjin 300060, Peoples R China
关键词
miR-143; NSCLC; Limk1; proliferation; migration; invasion; LUNG-CANCER CELLS; DOWN-REGULATION; MICRORNA-143; PROLIFERATION; EXPRESSION; MIGRATION; DIAGNOSIS; MOTILITY; INVASION;
D O I
10.3390/ijms150711973
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) have essential roles in carcinogenesis and tumor progression. Here, we investigated the roles and mechanisms of miR-143 in non-small cell lung cancer (NSCLC). miR-143 was significantly decreased in NSCLC tissues and cell lines. Overexpression of miR-143 suppressed NSCLC cell proliferation, induced apoptosis, and inhibited migration and invasion in vitro. Integrated analysis identified LIM domain kinase 1 (Limk1) as a direct and functional target of miR-143. Overexpression of Limk1 attenuated the tumor suppressive effects of miR-143 in NSCLC cells. Moreover, miR-143 was inversely correlated with Limk1 expression in NSCLC tissues. Together, our results highlight the significance of miR-143 and Limk1 in the development and progression of NSCLC.
引用
收藏
页码:11973 / 11983
页数:11
相关论文
共 50 条
  • [41] MicroRNA-130a targeting hypoxia-inducible factor 1 alpha suppresses cell metastasis and Warburg effect of NSCLC cells under hypoxia
    Shi, Jiang
    Wang, Huan
    Feng, Wanlu
    Huang, Siyuan
    An, Jinlu
    Qiu, Yajuan
    Wu, Kai
    LIFE SCIENCES, 2020, 255
  • [42] MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1
    Shi, L.
    Zhang, B.
    Sun, X.
    Lu, S.
    Liu, Z.
    Liu, Y.
    Li, H.
    Wang, L.
    Wang, X.
    Zhao, C.
    BRITISH JOURNAL OF CANCER, 2014, 111 (12) : 2316 - 2327
  • [43] miR-143 suppresses the proliferation of NSCLC cells by inhibiting the epidermal growth factor receptor
    Zhang, Hong-Bo
    Sun, Li-Chao
    Ling, Lan
    Cong, Lu-Hong
    Lian, Rui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (03) : 1795 - 1802
  • [44] miR-337-3p inhibits gastric tumor metastasis by targeting ARHGAP10
    Wang, Zishu
    Yao, Lun
    Li, Yu
    Hao, Bo
    Wang, Mingxi
    Wang, Junbin
    Gu, Wei
    Zhan, Huihui
    Liu, Guoquan
    Wu, Qiong
    MOLECULAR MEDICINE REPORTS, 2020, 21 (02) : 705 - 719
  • [45] MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1
    Zhao, Junyong
    Li, Dengfeng
    Fang, Lin
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 115
  • [46] Upregulation of miR-95-3p inhibits growth of osteosarcoma by targeting HDGF
    Liu, Xiwei
    Ma, Wei
    Ma, Jianbing
    Xiao, Lin
    Hao, Dingjun
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (08)
  • [47] Overexpression of LIMK1 promotes tumor growth and metastasis in gastric cancer
    You, Tiangeng
    Gao, Wei
    Wei, Jun
    Jin, Xiaoli
    Zhao, Zhongxin
    Wang, Congjun
    Li, Yang
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 69 : 96 - 101
  • [48] miR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1
    Liu, Chunxi
    Wang, Zhiyu
    Wang, Yi
    Gu, Wuwei
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2015, 398 (1-2) : 115 - 122
  • [49] miR-124 inhibits cell growth through targeting IQGAP1 in colorectal cancer
    Fan, Jianyu
    Zhang, Wenjing
    Wu, Yanting
    Wan, Ping
    Guo, Qiang
    Zhang, Yu
    MOLECULAR MEDICINE REPORTS, 2018, 18 (06) : 5270 - 5278
  • [50] miR-100 Inhibits Cell Growth and Proliferation by Targeting HOXA1 in Nasopharyngeal Carcinoma
    He, Weifeng
    Huang, Yun
    Jiang, Cheng Chuan
    Zhu, Yuan
    Wang, Ling
    Zhang, Weiwei
    Huang, Weiguo
    Zhou, Ting
    Tang, Sanyuan
    ONCOTARGETS AND THERAPY, 2020, 13 : 593 - 602